Surgery for Congenital Heart Disease Tied to Kidney Disease
Higher risk for ESKD, death suggests closer monitoring needed, especially in first year after surgery
Pediatrics
Ultomiris Receives Approval for Atypical Hemolytic Uremic Syndrome
The FDA has approved Ultomiris (ravulizumab-cwvz; Alexion) for the treatment of atypical hemolytic uremic syndrome (aHUS) to inhibit complement-mediated thrombotic microangiopathy (TMA) in adult and pediatric patients aged 1 month and older.
Global Prevalence of Pediatric Hypertension About 4%
Meta-analysis of 47 articles used to estimate pooled prevalence in the general pediatric population
Renal Anomaly on Fetal Scan May Up Risk for Admission for Child
Renal pelvis dilatation persisting in later pregnancy or after birth tied to increased risk for later admission
Study: Start Dialysis Later in Children
Children initiating dialysis at higher eGFRs had a 36% higher risk for death than those initiating at lower eGFRs.
FDA Approves Victoza Injection for Children 10 Years and Older
~64 percent of children treated with Victoza achieved HbA1c levels less than 7%
Exome Sequencing Beneficial for Pediatric Kidney Recipients
Whole-exome sequencing-related molecular genetic diagnosis can have implications for clinical care
Cinacalcet Appears Safe, Effective for Children With SHPT
In a small study, more than half of pediatric patients receiving cinacalcet experienced a 30% or greater decline in mean intact parathyroid hormone.
Racial Differences Observed in Pediatric SHPT
According to a study, black youth on dialysis have higher parathyroid hormone levels than white youth.
Cinacalcet Eases Refractory SHPT in Young Children
In a case series of 10 pediatric patients, goal iPTH was attained over a median 6 months.
Next post in Secondary Hyperparathyroidism
